Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5161 AL 5175

Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis

Alva G, Isaacson R, Sadowsky C, Grossberg G, Meng X, Somogyi M.

Int J Geriatr Psychiatry. 2014 Sep;29(9):920-7. doi: 10.1002/gps.4080. Epub 2014 Feb 18.

New York can be our nation's center for Alzheimer's research

Vann AS.

Am J Alzheimers Dis Other Demen. 2014 Sep;29(6):489-91. doi: 10.1177/1533317514523670. Epub 2014 Feb 18.

Cognitive behavioral group intervention for Alzheimer caregivers

Passoni S, Moroni L, Toraldo A, Mazzà MT, Bertolotti G, Vanacore N, Bottini G.

Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):275-82. doi: 10.1097/WAD.0000000000000033.

Sustained 4-year cognitive and functional response in early Alzheimer's disease with pioglitazone

Read S, Wu P, Biscow M.

J Am Geriatr Soc. 2014 Mar;62(3):584-6. doi: 10.1111/jgs.12722.

[Aspects of sustainability in outpatient health care for demented individuals]

Baumgardt J, Radisch J, Touil E, Moock J, Plewig HJ, Kawohl W, Rössler W.

Psychiatr Prax. 2014 Nov;41(8):424-31. doi: 10.1055/s-0033-1359974. Epub 2014 Mar 18.

Advances in understanding Alzheimer's disease, and the contributions of current Alzheimer research: ten years on and beyond

Greig NH, Lahiri DK.

Curr Alzheimer Res. 2014 Feb;11(2):107-9. doi: 10.2174/156720501102140313162901.

Apathy in Alzheimer's disease: any effective treatment?

Rea R, Carotenuto A, Fasanaro AM, Traini E, Amenta F.

ScientificWorldJournal. 2014 Feb 2;2014:421385. doi: 10.1155/2014/421385. eCollection 2014.

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

Nakamura Y, Kitamura S, Homma A, Shiosakai K, Matsui D.

Expert Opin Pharmacother. 2014 May;15(7):913-25. doi: 10.1517/14656566.2014.902446. Epub 2014 Mar 27.

Towards a better life with Alzheimer's disease

Lancet. 2014 Mar 29;383(9923):1100. doi: 10.1016/S0140-6736(14)60548-1.

Benefit-finding intervention for Alzheimer caregivers: conceptual framework, implementation issues, and preliminary efficacy

Cheng ST, Lau RW, Mak EP, Ng NS, Lam LC.

Gerontologist. 2014 Dec;54(6):1049-58. doi: 10.1093/geront/gnu018. Epub 2014 Mar 31.

The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical review

Reisberg B, Monteiro I, Torossian C, Auer S, Shulman MB, Ghimire S, Boksay I, Guillo BenArous F, Osorio R, Vengassery A, Imran S, Shaker H, Noor S, Naqvi S, Kenowsky S, Xu J.

Dement Geriatr Cogn Disord. 2014;38(1-2):89-146. doi: 10.1159/000357839. Epub 2014 Apr 7.

Nanocarrier-based approaches for treatment and detection of Alzheimer's disease

Oesterling BM, Gulati A, Joshi MD.

J Nanosci Nanotechnol. 2014 Jan;14(1):137-56. doi: 10.1166/jnn.2014.8906.

Public-private partnerships improve health outcomes in individuals with early stage Alzheimer's disease

Galvin JE, Tolea MI, George N, Wingbermuehle C.

Clin Interv Aging. 2014 Apr 10;9:621-30. doi: 10.2147/CIA.S60838. eCollection 2014.

A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor, PF-04447943, in Alzheimer's disease

Schwam EM, Nicholas T, Chew R, Billing CB, Davidson W, Ambrose D, Altstiel LD.

Curr Alzheimer Res. 2014;11(5):413-21. doi: 10.2174/1567205011666140505100858.

The Effectiveness of a Culturally Sensitive Cognitive Behavioral Group Intervention for Latino Alzheimer's Caregivers

Gonyea JG, López LM, Velásquez EH.

Gerontologist. 2016 Apr;56(2):292-302. doi: 10.1093/geront/gnu045. Epub 2014 May 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias